Kinetikos wins a grant for Parkinson´s Disease innovation and technological development
It´s been a year of challenges, especially in the healthcare sector, which has been pushed to adopt telehealth solutions and rethink digital tools that boost convenience, improve care and disease management and reduce hospitalization rates for high-risk adults. But also to patients who need us more than ever. This is good news to the way digital health innovations shape a new future for better care and support.
Now going back to the title, you read it right! Kinetikos won a grant from Portugal2020 — Centro 2020 to reinforce the investigation, technological development and innovation of Kinetikos4PD, a continuum and integrated person-centered solution that brings scientific accurate movement classification tools to Parkinson’s Disease treatment and enables remote care. 👏👏👏
Kinetikos4PD (Parkinson´s Disease) is an information and communications technology (ICT) based solution that addresses the European Union’s societal challenge on ‘Health, demographic change, and well-being’ by providing a highly innovative and more effective solution that pushes PD therapy and care towards digitalization.
This project aims to:
- Create a person-centered solution that incorporates the biopsychosocial dimension for the treatment and management of the Parkinson’s Disease;
- Create a bidirectional communication channel between healthcare professionals, caregivers, and patients;
- Accurately map the multidimensional Parkinson Disease allowing a wider knowledge about it.
Portugal2020 is the partnership agreement between Portugal and the European Commission, which brings together the five European Structural and Investment Funds (ESIF). This project is under CENTRO 2020, a Portugal2020 regional program, that aims to achieve more satisfactory levels of economic, social and territorial cohesion, which means strengthening investment in areas such as competitiveness, research, development, and innovation, with a particular focus on technology transfer and SMEs and knowledge-generating entities.
Want to know more? Find out more on our website.